Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Andrea Gonella, Sylvestre Grizot, Fang Liu, Adolfo López Noriega & Joël Richard. (2022) Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules. Expert Opinion on Drug Delivery 19:8, pages 927-944.
Read now
Read now
Mohamed A. Shaker, Jules J. E. Doré & Husam M. Younes. (2022) Controlled release of bioactive IL-2 from visible light photocured biodegradable elastomers for cancer immunotherapy applications. Pharmaceutical Development and Technology 27:1, pages 40-51.
Read now
Read now
Nataša Škalko-Basnet. (2014) Biologics: the role of delivery systems in improved therapy. Biologics: Targets and Therapy 8, pages 107-114.
Read now
Read now
Reinhard Reuss. (2013) PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update. Biologics: Targets and Therapy 7, pages 131-138.
Read now
Read now
Vladimir N Uversky. (2013) The alphabet of intrinsic disorder. Intrinsically Disordered Proteins 1:1.
Read now
Read now
José Vicente González-Aramundiz, María Victoria Lozano, Ana Sousa-Herves, Eduardo Fernandez-Megia & Noemi Csaba. (2012) Polypeptides and polyaminoacids in drug delivery. Expert Opinion on Drug Delivery 9:2, pages 183-201.
Read now
Read now
Articles from other publishers (40)
Marcus Wanselius, Sean Searle, Agnes Rodler, Maria Tenje, Susanna Abrahmsén-Alami & Per Hansson. (2022) Microfluidics platform for studies of peptide – polyelectrolyte interaction. International Journal of Pharmaceutics 621, pages 121785.
Crossref
Crossref
May Wenche Jøraholmen, Selenia Ternullo, Ann Mari Holsæter, Gøril Eide Flaten & Nataša Škalko‐Basnet. 2021. Fundamentals of Drug Delivery. Fundamentals of Drug Delivery
231
261
.
Xiangxue Lyu, Qiufen Zhang, Dehai Liang & Yanbin Huang. (2019) Interaction between human serum albumin and cholesterol-grafted polyglutamate as the potential carriers of protein drugs. Acta Pharmaceutica Sinica B 9:1, pages 186-193.
Crossref
Crossref
Christoph Englert, Johannes C. Brendel, Tobias C. Majdanski, Turgay Yildirim, Stephanie Schubert, Michael Gottschaldt, Norbert Windhab & Ulrich S. Schubert. (2018) Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications. Progress in Polymer Science 87, pages 107-164.
Crossref
Crossref
Antoine Henninot, James C. Collins & John M. Nuss. (2017) The Current State of Peptide Drug Discovery: Back to the Future?. Journal of Medicinal Chemistry 61:4, pages 1382-1414.
Crossref
Crossref
Ludger M Ickenstein & Patrick Garidel. (2018) Hydrogel formulations for biologicals: current spotlight from a commercial perspective. Therapeutic Delivery 9:3, pages 221-230.
Crossref
Crossref
Uli Binder & Arne Skerra. (2017) PASylation®: A versatile technology to extend drug delivery. Current Opinion in Colloid & Interface Science 31, pages 10-17.
Crossref
Crossref
Jianfeng Zhang, Ben Muirhead, Megan Dodd, Lina Liu, Fei Xu, Nicole Mangiacotte, Todd Hoare & Heather Sheardown. (2016) An Injectable Hydrogel Prepared Using a PEG/Vitamin E Copolymer Facilitating Aqueous-Driven Gelation. Biomacromolecules 17:11, pages 3648-3658.
Crossref
Crossref
. 2016. Drug Delivery. Drug Delivery
137
167
.
Laurent Leclercq, Xiaoyun Jin & Hervé Cottet. 2007. Encyclopedia of Analytical Chemistry. Encyclopedia of Analytical Chemistry
1
25
.
Shizhu Chen, Keni Yang, Ruslan G. Tuguntaev, Anbu Mozhi, Jinchao Zhang, Paul C. Wang & Xing-Jie Liang. (2016) Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine: Nanotechnology, Biology and Medicine 12:2, pages 269-286.
Crossref
Crossref
Andrew L Lewis & Joël Richard. (2015) Challenges in the delivery of peptide drugs: an industry perspective. Therapeutic Delivery 6:2, pages 149-163.
Crossref
Crossref
Alexandra Beumer Sassi, Radhika Nagarkar & Paul Hamblin. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
199
217
.
Kenneth Lundstrom. 2015. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies. Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies
15
39
.
Won Il Choi, Nazila Kamaly, Lorena Riol-Blanco, In-Hyun Lee, Jun Wu, Archana Swami, Cristian Vilos, Basit Yameen, Mikyung Yu, Jinjun Shi, Ira Tabas, Ulrich H. von Andrian, Sangyong Jon & Omid C. Farokhzad. (2014) A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins. Nano Letters 14:11, pages 6449-6455.
Crossref
Crossref
Samir Mitragotri, Paul A. Burke & Robert Langer. (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nature Reviews Drug Discovery 13:9, pages 655-672.
Crossref
Crossref
Nicolas Duhem, Fabienne Danhier & Véronique Préat. (2014) Vitamin E-based nanomedicines for anti-cancer drug delivery. Journal of Controlled Release 182, pages 33-44.
Crossref
Crossref
Christophe BourdeauxChristophe Lurquin, Isabelle Jacquemart, Bernard Lethé, Francis Brasseur, Nicolas van Baren, Jean-François BaurainJulian Dyson, Jacques Van Snick, Catherine Uyttenhove & Thierry Boon. (2014) Local immunostimulation leading to rejection of accepted male skin grafts by female mice as a model for cancer immunotherapy. Proceedings of the National Academy of Sciences 111:9, pages 3502-3507.
Crossref
Crossref
Xiaoyun Jin, Laurent Leclercq & Hervé Cottet. (2013) Determination of polymer log D distributions by micellar and microemulsion electrokinetic chromatography. Journal of Chromatography A 1318, pages 244-250.
Crossref
Crossref
Amal Ibrahim, Rémi Meyrueix, Gauthier Pouliquen, You Ping Chan & Hervé Cottet. (2013) Size and charge characterization of polymeric drug delivery systems by Taylor dispersion analysis and capillary electrophoresis. Analytical and Bioanalytical Chemistry 405:16, pages 5369-5379.
Crossref
Crossref
Mariano Licciardi, Giovanna Pitarresi, Gennara Cavallaro & Gaetano Giammona. (2013) Nanoaggregates Based on New Poly-Hydroxyethyl-Aspartamide Copolymers for Oral Insulin Absorption. Molecular Pharmaceutics 10:5, pages 1644-1654.
Crossref
Crossref
Sibyll Pollok, Torsten Ginter, Katharina Günzel, Jana Pieper, Andreas Henke, Roland H. Stauber, Werner Reichardt & Oliver H. Krämer. (2013) Interferon alpha-armed nanoparticles trigger rapid and sustained STAT1-dependent anti-viral cellular responses. Cellular Signalling 25:4, pages 989-998.
Crossref
Crossref
Abeer H. A. Mohamed-AhmedKarolina A. LesKarin SeifertSimon L. CroftStephen Brocchini. (2013) Noncovalent Complexation of Amphotericin-B with Poly(α-glutamic acid). Molecular Pharmaceutics 10:3, pages 940-950.
Crossref
Crossref
Vanessa M.S. Duncan & Deborah A. O'Neil. (2013) Commercialization of antifungal peptides. Fungal Biology Reviews 26:4, pages 156-165.
Crossref
Crossref
Qian Liu & Weiliang Xia. 2013. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine
231
242
.
Shobhan Sabnis & Michael J. Rathbone. 2013. Long Acting Animal Health Drug Products. Long Acting Animal Health Drug Products
1
14
.
Jing Sun, Juliette Ruchmann, A. Pallier, L. Jullien, M. Desmadril & Christophe Tribet. (2012)
Unfolding of Cytochrome
c
upon Interaction with Azobenzene-Modified Copolymers
. Biomacromolecules 13:11, pages 3736-3746.
Crossref
Crossref
Takashi Nakai, Tai Hirakura, Yuji Sakurai, Tsuyoshi Shimoboji, Masaki Ishigai & Kazunari Akiyoshi. (2012) Injectable Hydrogel for Sustained Protein Release by Salt‐Induced Association of Hyaluronic Acid Nanogel. Macromolecular Bioscience 12:4, pages 475-483.
Crossref
Crossref
Carla A. Borgoño & Bernard Zinman. (2012) Insulins: Past, Present, and Future. Endocrinology and Metabolism Clinics of North America 41:1, pages 1-24.
Crossref
Crossref
William Kemp & Stuart K. Roberts. 2012. Chronic Hepatitis C Virus. Chronic Hepatitis C Virus
115
130
.
Cynthia L. Stevenson, Christopher A. Rhodes & Steven J. Prestrelski. 2012. Long Acting Injections and Implants. Long Acting Injections and Implants
409
427
.
Lin Bi, Lei Yang, Ganesan Narsimhan, Arun K. Bhunia & Yuan Yao. (2011) Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide. Journal of Controlled Release 150:2, pages 150-156.
Crossref
Crossref
Jeremy D. Heidel & Mark E. Davis. (2010) Clinical Developments in Nanotechnology for Cancer Therapy. Pharmaceutical Research 28:2, pages 187-199.
Crossref
Crossref
Andrew L Lewis & Lisbeth Illum. (2010) Formulation strategies for sustained release of proteins. Therapeutic Delivery 1:3, pages 457-479.
Crossref
Crossref
Dipak S. Pisal, Matthew P. Kosloski & Sathy V. Balu-Iyer. (2010) Delivery of Therapeutic Proteins. Journal of Pharmaceutical Sciences 99:6, pages 2557-2575.
Crossref
Crossref
Tai Hirakura, Kenji Yasugi, Takayuki Nemoto, Mika Sato, Tsuyoshi Shimoboji, Yoshinori Aso, Nobuyuki Morimoto & Kazunari Akiyoshi. (2010) Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: New system for sustained delivery of protein with a chaperone-like function. Journal of Controlled Release 142:3, pages 483-489.
Crossref
Crossref
Kenneth Lundstrom. 2009. Delivery Technologies for Biopharmaceuticals. Delivery Technologies for Biopharmaceuticals
193
205
.
Sabine Ponader, Heike Brandt, Eleftherios Vairaktaris, Cornelius von Wilmowsky, Wolfgang Göthel, Rainer Lutz, Karl A. Schlegel, Friedrich W. Neukam, Peter Greil, Frank A. Müller & Emeka Nkenke. (2009) In vivo Performance of Osteoactivated Cellulose‐Based Scaffolds in Bony Critical‐Size Defects. Advanced Engineering Materials 11:8.
Crossref
Crossref
Mohamed A. Shaker & Husam M. Younes. (2009) Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer Therapy. Journal of Pharmaceutical Sciences 98:7, pages 2268-2298.
Crossref
Crossref
Sumalee Thitinan & Jason T. McConville. (2009) Interferon alpha delivery systems for the treatment of hepatitis C. International Journal of Pharmaceutics 369:1-2, pages 121-135.
Crossref
Crossref